NCT04354051View on ClinicalTrials.gov

The Nitrite and Coronary Flow Study

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

December 1, 2018

Study Completion Date

December 1, 2018

Conditions
Cardiovascular DiseasesVasodilationHypoxia
Interventions
DRUG

Sodium Nitrite

Intravenous nitrite sodium infusion, dose 70μmol, of 5 minute duration (14μmol /min-1).

Trial Locations (1)

NR4 7TJ

University of East Anglia, Norwich

All Listed Sponsors
collaborator

Royal Brompton & Harefield NHS Foundation Trust

OTHER

lead

University of East Anglia

OTHER

NCT04354051 - The Nitrite and Coronary Flow Study | Biotech Hunter | Biotech Hunter